our international baner


Against the backdrop of aging populations, personalised medicine, social care challenges and a clear need to drive efficiencies; businesses in the sector continue to be very attractive to buyers and investors.

Healthcare is a broad sector which encompasses everything from domiciliary care providers to private health and aesthetic care clinics, from contract research organisations to gene editing companies and from Healthcare IT (HCIT) to medical instrumentation.

With a vast global market to address, the sector is highly regulated, creating demanding barriers to entry. At the same time the purchasing cycle can be frustratingly long and the route to market, particularly in the public sector, is a real challenge for new technologies and business offerings. As a result of this, healthcare businesses often require multiple rounds of investment and/or M&A to realise their potential.

While the press tends to focus on mega pharmaceutical and biotechnology-led transactions, the services focussed mid-market is also highly active, with private equity investors and acquirers keen to identify the likely winners in a well-spread field of runners.

HMT’s Credentials

The HMT team has a range of experience across the healthcare sector including equity and debt raises and advice to private and institutional vendors and acquirers in the following sub-sectors:

  • Health-tech
  • Research & Medical

It is critical that businesses understand their specific place in a complex industry and can articulate the factors which will drive their success, be they intellectual property based or delivery led.

Because of the buying environment for healthcare, the time to market can be elongated and investors and acquirers will look for evidence of market engagement. Identifying the right funder or acquirer to ensure “fit” is key to funding or M&A success and HMT’s experience of the funding market and the global reach which ICFG affords us helps us match businesses in the sector with their perfect partner.


Our team has undertaken many transactions in the Healthcare sector and has recently advised on acquisitions, fundraisings and disposals of biopharmaceutical companies, healthcare consultancies and genetic research companies amongst others.


Industry Commentary


Latest News